Invokana

If you suffered a leg or foot amputation after using Invokana, Invokamet, or Invokamet XR, you may be entitled to a cash award.

Two recent clinical trials – the CANVAS (Canagliflozin Cardiovascular Assessment Study) and CANVAS-R (A Study of the Effects of Canagliflozin on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus) – revealed that patients taking canagliflozin (Invokana, Invokamet, and Invokamet XR) were almost twice as likely to experience leg and foot amputations compared to patients taking a placebo. The most common amputations were of toes and middle of the foot; leg amputations both above and below the knee were also observed. This risk of amputation may be higher for people with peripheral vascular disease, diabetic foot ulcers (sores), neuropathy (nerve damage), and patients who have had an amputation in the past.

How It Works

While some diabetes medications work by making the body more sensitive to insulin or by making the body secrete more insulin, Invokana treats diabetes by causing the kidneys to remove sugar from the body through the urine. As a result, blood sugar is lowered and the effects of diabetes are reduced.

Other Side Effects

The increased risk of leg and foot amputation linked to Invokana is a new finding. However, several other side effects have been known for some time. These include:
  Cardiovascular Problems
  Kidney Damage
  Heart Attack
  Ketoacidosis

If you or a loved one have had a leg or foot amputation, suffered kidney damage, a heart attack, or ketoacidosis, you may be entitled to money damages. Call the Gold Shield Group at 877-575-4853.

Free Consultation

Call now at 877-575-4853 or complete our form for a FREE, no-obligation case evaluation.
Your name:
Your contact information
Best time to reach you:
*By submitting this form, I am granting permission to be contacted via phone, email, text or any other means. I am also confirming that I understand that no attorney-client relationship exists without a specific written retainer agreement between myself and a law firm.